Latest Headlines
-
Anbio Biotechnology To Showcase At ADLM 2024 With Evolved In Vitro Diagnostic Solutions
7/1/2024
Anbio Biotechnology ("Anbio"), a leading global diagnostic solution provider, is excited to announce its participation in the ADLM 2024 Clinical Lab Expo (formerly the AACC Clinical Lab Expo).
-
Epigenetic Laboratory Trudiagnostic Launches First Ever Organ-Specific Aging Analysis From Yale-Developed Symphonyage Algorithms
6/28/2024
Marking a milestone development in epigenetic research and clinical health applications, laboratory TruDiagnostic is launching the first ever, epigenetic aging analysis of individual organ systems, using validated and system-specific trained clocks.
-
Thermo Fisher Scientific Expands Clinical Research Laboratory In Kentucky
6/27/2024
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today announced the expansion of its central laboratory operations in Kentucky dedicated to accelerating pharmaceutical and biotech customers’ delivery of safe, effective medicines to patients.
-
C2N's Precivity Tests Are Now Offered Through Mayo Clinic Laboratories
6/27/2024
C2N Diagnostics, LLC (“C2N”), which provides exceptional clinical laboratory services and advanced diagnostic solutions in the field of brain health, has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for inclusion of C2N’s Precivity tests in Mayo Clinic Laboratories’ test offerings to its clients.
-
FDA Permits Marketing Of First Point-Of-Care Hepatitis C RNA Test
6/27/2024
Today, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used to bring diagnosis to appropriately certified point-of-care settings for individuals at risk for hepatitis C.
-
QPS Announces New Laboratory Services For Clinical Trials And Cell Therapy Development
6/26/2024
QPS, a leading global contract research organization (CRO), is pleased to announce new laboratory services capabilities
-
Quest Diagnostics To Acquire Select Lab Assets From Allina Health
6/26/2024
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, and Allina Health, a leading, non-profit health care system, today announced a definitive agreement for Quest to acquire select laboratory assets from Allina Health, with the goal to improve access to and the affordability of innovative laboratory services across Minnesota and western Wisconsin.
-
Sapio Sciences Introduces Sapio GMP LIMS Offering Unmatched Flexibility For Unique Manufacturing Processes
6/25/2024
Sapio Sciences, the science-aware lab informatics platform, today announced the Sapio GMP (Good Manufacturing Practice) LIMS for laboratories that require unparalleled flexibility to meet manufacturing compliance standards.
-
BioAI And Genomic Testing Cooperative Announce Strategic Collaboration To Provide AI-Powered Digital Pathology Solutions For Clinical Research And Diagnostic Applications
6/25/2024
BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, announced a strategic collaboration with Genomic Testing Cooperative (GTC), a leading provider of molecular diagnostics for solid tumors and hematologic malignancies.
-
Association For Diagnostics & Laboratory Medicine (Formerly AACC) Survey Finds That FDA's Final Laboratory Developed Tests Rule Will Impede The Fight Against The U.S.'S Drug Epidemic
6/25/2024
Today, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) released the results of a survey that ADLM conducted to determine how the Food and Drug Administration's (FDA's) final laboratory developed tests rule will impact patient access to essential tests.